Follicular lymphoma grade II, lymph nodes of inguinal region and lower limb
ICD-10 C82.15 is a billable code used to indicate a diagnosis of follicular lymphoma grade ii, lymph nodes of inguinal region and lower limb.
Follicular lymphoma grade II is a type of non-Hodgkin lymphoma characterized by the proliferation of follicle center (germinal center) B-cells. This subtype is typically indolent but can transform into a more aggressive form. The involvement of lymph nodes in the inguinal region and lower limb indicates a specific anatomical localization of the disease. Patients may present with painless lymphadenopathy, and the disease can be associated with B-symptoms such as fever, night sweats, and weight loss. Staging of follicular lymphoma is crucial for determining prognosis and treatment options, with the Ann Arbor staging system commonly used. Treatment protocols may include watchful waiting for asymptomatic patients, chemotherapy, immunotherapy, or radiation therapy, depending on the stage and symptoms. The prognosis varies, with factors such as age, performance status, and the presence of B-symptoms influencing outcomes.
Detailed clinical notes on staging, treatment plans, and follow-up care.
Diagnosis of follicular lymphoma, treatment initiation, and monitoring for transformation.
Ensure accurate documentation of B-symptoms and treatment responses.
Histopathological reports confirming the diagnosis and grade of lymphoma.
Biopsy interpretation and grading of lymphoid tissue.
Clear communication of findings to support coding and treatment decisions.
Used for patients receiving chemotherapy for follicular lymphoma.
Document the specific chemotherapy regimen and patient response.
Oncology specialists should ensure accurate coding of chemotherapy sessions.
Common treatments include watchful waiting for asymptomatic patients, chemotherapy regimens such as R-CHOP, and immunotherapy options like rituximab. Radiation therapy may also be considered in localized cases.
